While U.K. media group BSkyB has expressed cautious optimism that 4K broadcasting may be possible in just a few years' time, South Korea's consumer electronics giants are even further ahead of the curve ��initial tests of 4K broadcasts began earlier this summer, sponsored by LG.
The race is on, but one country is running on an entirely different track. In June, more than 20 competing Japanese manufacturers and broadcasters ��including Sony, Sharp, Toshiba, Panasonic, NTV and the NHK ��put aside their differences and joined forces in a government-backed collaborative forum called "NexTV-F."
Top 5 International Companies To Own In Right Now: American States Water Co (AWR)
American States Water Company (AWR), incorporated on February 25, 1998, is the parent company of Golden State Water Company (GSWC) and American States Utility Services, Inc. (ASUS) and its subsidiaries (Fort Bliss Water Services Company (FBWS), Terrapin Utility Services, Inc. (TUS), Old Dominion Utility Services, Inc. (ODUS), Palmetto State Utility Services, Inc. (PSUS) and Old North Utility Services, Inc. (ONUS)). AWR operates in three segments: water, electric and contracted services. Within the segments, AWR has two principal business units, water and electric service utility operations, conducted through GSWC, and contracted services conducted through ASUS and its subsidiaries.
GSWC is a California public utility company engaged principally in the purchase, production and distribution of water in 75 communities in 10 counties in the State of California. GSWC also provides electric service to the City of Big Bear Lake and surrounding areas in San Bernardino County, California through its Bear Valley Electric Service (BVES) division. GSWC served 255,657 water customers and 23,379 electric customers as of December 31, 2012. ASUS, through its wholly owned subsidiaries, has contracted with the United States government to provide water and/or wastewater services at various military installations, including the operation, maintenance, renewal and replacement of the water and/or wastewater systems, pursuant to 50-year firm, fixed-price contracts. As of December 31, 2012, GSWC�� physical properties consisted of water transmission and distribution systems which included 2,786 miles of pipeline together with services, meters and fire hydrants and approximately 425 parcels of land.
As of December 31, 2012, GSWC owned 244 wells, of which 188 are active operable wells equipped with pumps with an aggregate production capacity of approximately 202.7 million gallons per day. GSWC has 63 connections to the water distribution facilities of the Metropolitan Water District of Southern Cali! fornia (MWD), and other municipal water agencies. GSWC�� storage reservoirs and tanks have an aggregate capacity of approximately 111 million gallons. GSWC owns no dams. GSWC�� electric properties are located in the Big Bear area of San Bernardino County, California. As of December 31, 2012, GSWC owned and operated 29.6 miles of overhead 34.5 kilovolt transmission lines, 1.4 mile of underground 34.5 kilovolt transmission lines, 179.6 miles of 4.16 kilovolt or 2.4 kilovolt distribution lines, 53.2 miles of underground cable, 13 sub-stations and a natural gas-fueled 8.4 megawatt peaking generation facility. GSWC also has franchises, easements and other rights of way for the purpose of constructing and using poles, wires and other appurtenances for transmitting electricity.
Advisors' Opinion:- [By Insider Monkey]
American States Water (AWR), meanwhile, is another dividend giant that has seen bullish insider activity of late. The Western US-focused water utilities company has raised dividends in 59 straight years and currently offers a yield of 2.9%. Somewhat astoundingly, American's payout ratio (47%) is still below its industry's average (59%), so the dividend growth doesn't look set to end anytime soon.
Top Japanese Stocks To Invest In Right Now: Emulex Corp (ELX)
Emulex Corporation (Emulex) is a provider of a range of network convergence solutions that connect servers, storage, and networks within the data center. The Company�� product portfolio includes Host Bus Adapters (HBAs), Converged Network Adapters (CNAs), Network Interface Cards (NICs), mezzanine cards for blade servers, Application Specific Integrated Circuits (ASICs), embedded storage bridges, routers, and switches, Input/Output Controllers (IOCs), and connectivity management solutions. The Company is a designer, developer and supplier of HBAs, CNAs, NICs, mezzanine cards, Pass-Through Modules (PTM), embedded storage switches, embedded bridges, embedded routers, I/O ASICs, switch-on-a-chip (SOC) ASICs, Internet Baseboard management controllers (iBMC��) and connectivity management solutions. On August 25, 2010, Emulex acquired ServerEngines Corporation. In February 2013, Emulex acquired 89% ownership of Endace Ltd. In April 2013, Emulex Corp announced the completion of acquisition of Endace Limited.
Host Server Products
The Company�� Host Server Products include the development of chip level and board level server-based I/O adapters, including HBAs, Universal Converged Network Adapters (UCNAs), and mezzanine cards that connect servers and storage to networks using a range of products. Its products support Internet protocol (IP) and storage networking, including transmission control protocol (TCP)/IP, Internet small computer system interface (iSCSI), network attached storage (NAS), Fibre Channel, and Fibre Channel over Ethernet (FCoE). Host Server Products (HSP) include LightPulse HBAs, OneConnecttm UCNAs, custom form factor solutions for original equipment manufacturer (OEM) blade servers, and ASICs. These products enable servers to connect to local area networks (LANs), storage area networks (SANs), and NAS by offloading data communication processing tasks from the server as information is delivered and sent to the network.
Its Fibre Channel H! BAs connect host computers to a Fibre Channel network. The Company�� adapters support a range of operating systems and host computer system interfaces, including Peripheral Component Interconnect (PCI) and PCI Express-based platforms. Its Fibre Channel HBA offerings include single, dual, and quad port adapters at throughput speeds of two gigabyte per second, four gigabyte per second, and eight gigabyte per second for use in enterprise, large, medium, and small-sized organizations. The Emulex OneConnect UCNA is a single chip 10 gigabyte per second Ethernet platform designed to address the challenges of data center networks. The Emulex UCNA platform enables data center managers to consolidate multiple one gigabyte per second Ethernet links on to a single 10 gigabyte per second Ethernet link. Emulex HBAs and UCNAs are based upon its internally developed Fibre Channel and Ethernet IOCs. In addition, these IOCs can be used in embedded I/O environments, such as disk and tape storage arrays and storage appliances. Revenues from these applications are included in the Company�� Embedded Storage Products.
Embedded Storage Products
The Company�� Embedded Storage Products include the development of chip level, board level, and box level array based products that are deployed inside storage arrays, tape libraries, and other storage products to provide connectivity and protocol emulation functions. These products include embedded IOCs, I/O Processors (IOPs), SOCs, embedded bridges (FC/SATA/SAS), and embedded routers (FC/SATA/SAS). Emulex offers a range of integrated, embedded storage networking products for enterprise storage systems that deliver improved performance, reliability and storage connectivity. InSpeed is an advanced switching architecture that results in a single chip capable of handling multiple Fibre Channel devices operating at two, four, or eight gigabyte per second speeds. Its embedded router and bridge products consist of chip and firmware solutions.
! The Compa! ny competes with QLogic Corporation, Brocade Communications Systems, Inc., Broadcom Corporation, Intel Corporation, Chelsio Communications, Inc., Mellanox Technologies, Ltd., LSI, Marvell Technology Group Ltd., Maxim Integrated Products, Inc. and PMC-Sierra, Inc.
Advisors' Opinion:- [By John Udovich]
Mid cap networking solutions company Brocade Communications Systems, Inc (NASDAQ: BRCD) has pretty much been a sleeper for investors since the dot.com bust, but that has changed over the past year���meaning its worth revisiting the stock along with potential performance benchmarks�like QLogic Corporation (NASDAQ: QLGC), Emulex Corporation (NYSE: ELX) and iShares North American Tech-Multimedia Networking ETF (NYSEARCA: IGN). I should mention that we have recently Brocade Communications Systems to our SmallCap Network Elite Opportunity (SCN EO) portfolio because the company has successfully transitioned from being a hardware company to supporting virtual networks via software and it continues to offer best-of-breed technology.
- [By Eric Volkman]
A top-level promotion has taken place at Emulex (NYSE: ELX ) . The company announced that it has appointed Jeffrey Benck to be its CEO, effective immediately. He replaces James McCluney, who was named executive chairman of the board. In turn, McCluney displaces ex-chairman Paul Folino, who is to continue to serve as a director.
Top Japanese Stocks To Invest In Right Now: Forest Laboratories Inc (FRX)
Forest Laboratories, Inc. (Forest), incorporated on April 11, 1956, develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. Its products include those developed by the Company and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. The Company�� principal products include Lexapro, its selective serotonin reuptake inhibitor (SSRI) for the treatment of major depressive disorder (MDD) in adults and adolescents and generalized anxiety disorder (GAD) in adults; Namenda, its N-methyl-D-Aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension; Savella, its selective serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia and its newest marketed product Teflaro, a broad-spectrum hospital-based injectable cephalosporin antibiotic for the treatment of adults with community-acquired bacterial pneumonia. On April 13, 2011, the Company acquired Clinical Data Inc. (Clinical Data), a specialty pharmaceutical company.
Aclidinium
In June 2011, the Company ahs submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for aclidinium (aclidinium bromide), a long-acting antimuscarinic agent developed as an inhaled therapy for the maintenance treatment of chronic obstructive pulmonary disease (COPD). When given by inhalation, aclidinium leads to bronchodilation by inhibiting airway smooth muscle contraction. Aclidinium is rapidly hydrolyzed in human plasma to two major inactive metabolites. Aclidinium is administered to patients using a multi-dose dry powder inhaler (MDPI). This inhaler was designed with a feedback system which, through a ��olored control window��and an a! udible click, helps confirm that the patient has inhaled correctly. It contains multiple doses of aclidinium, includes a visible dose-level indicator, and also incorporates features such as an anti-double dosing mechanism and an end-of-dose lock-out system to prevent use of an empty inhaler.
Linaclotide
Linaclotide is being investigated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation (CC). Linaclotide is an agonist of the guanylate cyclase type-C receptor found in the intestine and acts by a mechanism. Linaclotide increases fluid secretions leading to increased bowel movement frequency and reduces abdominal pain. Linaclotide is administered orally but acts locally in the intestine with no measurable systemic exposure at therapeutic doses and is intended for once-daily administration.
Viibryd
As a result of its acquisition of Clinical Data, Inc. (Clinical Data) completed in April 2011, the Company obtained worldwide rights to develop and market Viibryd (vilazodone HCl) a selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist developed by Clinical Data for the treatment of adults with major depressive disorder (MDD). Viibryd became available to patients during the June 2011 quarter and was formally launched in the U.S. in late August 2011.
Daliresp
In February 2011, the Company received approval from the United States Food and Drug Administration (FDA) for the marketing of Daliresp (roflumilast). Daliresp is once-daily, orally administered, selective phosphodiesterase 4 (PDE4) enzyme inhibitor, developed by its partner, Nycomed GmbH (Nycomed), as a treatment to reduce the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations.
Namenda
Namenda (memantine HCl) is an N-methyl-D-Aspartate (NMDA) receptor agonist for the treatmen! t of mode! rate and severe Alzheimer�� disease. In June 2010, Namenda XR was approved by the FDA for the treatment of moderate to severe dementia of the Alzheimer�� type. Namenda XR is a 28 milligrams once-daily extended-release formulation of Namenda. The Company has obtained the exclusive rights to develop and market memantine in the United States by license agreement with Merz Pharma GmbH & Co. KgaA (Merz) of Germany, the originator of the product.
Bystolic
Bystolic is a beta-1 selective beta-blocker with vasodilating properties. Bystolic decreases heart rate and myocardial contractility and suppresses rennin activity. The Company licensed exclusive United States and Canadian rights to Bystolic from Mylan Inc. (Mylan).
Savella
Savella (milnacipran HCl) is the Company�� selective serotonin and norepinephrine inhibitor (SNRI) for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function. The Company licensed the United States and Canadian rights to develop and commercialize Savella from Cypress Bioscience, Inc. (Cypress). Its license agreement includes two patents covering the use of Savella for the management of fibromyalgia.
Teflaro
In October 2010, the Company received marketing approval from the FDA for Teflaro (ceftaroline) for the treatment of adults with community-acquired bacterial pneumonia, including cases caused by Streptococcus pneumoniae bacteremia and with acute bacterial skin and skin structure infections, including cases caused by methicillin-resistant Staphylococcus aureus. Teflaro is a spectrum, hospital-based injectable cephalosporin antibiotic with activity against Gram-positive bacteria and common Gram-negative bacteria. Teflaro is a member of the cephalosporin class of antibiotics. The worldwide rights (excluding Japan) to Teflaro are in-licensed on an exclusive basis from Takeda Pharmaceutical Company (Takeda). Teflaro is als! o covered! by two United States patents that relate to the ceftaroline formulation that expire in 2021 and that may provide additional exclusivity.
Avibactam
Avibactam is designed to be co-administered with select antibiotics to enhance their spectrum of activity. The Company received the exclusive rights to administer avibactam with ceftaroline as a combination product in North America. Avibactam is a beta-lactamase inhibitor designed to be co-administered with select antibiotics to enhance their spectrum of activity by overcoming beta-lactamase-related antibacterial resistance.
Lexapro
Lexapro�� is a SSRI for the treatment of MDD in adults and adolescents and GAD in adults. Lexapro�� (escitalopram oxalate) single isomer version of citalopram HBr, for the treatment of MDD in adults and adolescents and GAD in adults.
Cariprazine
Cariprazine is an oral D2/D3 partial agonist. Cariprazine is also undergoing Phase III trials for schizophrenia and acute mania associated with bipolar depression, bipolar depression and as an adjunct treatment for MDD.
Levomilnacipran
Levomilnacipran is a once-daily, selective norepinephrine and serotonin reuptake inhibitor, two neurotransmitters known to play an essential role in regulating mood, and is being developed for the treatment of MDD.
GRT 6005
In December 2010, the Company entered into a license agreement with Grunenthal GmbH for the co-development and commercialization of GRT 6005 and its follow-on compound GRT 6006, small molecule analgesic compounds being developed by Grunenthal for the treatment of moderate to severe chronic pain. GRT 6005 and GRT 6006 are compounds with pharmacological and pharmacokinetic profiles that may enhance their effect in certain pain conditions. GRT 6005 has completed initial proof-of-concept studies in nociceptive and neuropathic pain with further Phase II studies planned prior to initiation of Phase III s! tudies.
TTP399
In June 2010, the Company entered into a license agreement with TransTech Pharma, Inc. (TransTech) for the development and commercialization of TTP399, a functionally liver selective glucokinase activator (GKA) discovered and developed by TransTech for the treatment of Type II diabetes. Early Phase I testing suggests that pharmacological enhancement of glucokinase activity may lower blood glucose in diabetic patients.
Azimilide
In April 2011, the Company entered into an agreement with Blue Ash Therapeutics, LLC (Blue Ash) pursuant to which it acquired the worldwide rights to azimilide, a class III antiarrhythmic agent developed by Proctor & Gamble Pharmaceuticals. Based on its mechanism of action and results of clinical trials, azimilide was determined to be suited for use in patients with a history of life-threatening ventricular arrhythmias and who have an implantable cardioverter defibrillator. In 2010, the FDA agreed to one additional Phase III study to support a regulatory submission for azimilide in the U.S.
RGH-618
RGH-618 involves a series of compounds that target metabotropic glutamate receptors and are agonists, which represent potential agents for the treatment of anxiety, depression and other central nervous system (CNS) conditions. In March 2012, the Company initiated a Phase I study in healthy volunteers of RGH-618.
Advisors' Opinion:- [By Brian Marckx]
Several large pharma companies have OA drug candidates in various stages of clinical trials including GlaxoSmithKline (GSK), Abbott Laboratories (ABT), and Forest Laboratories (FRX) and would have potentially significant interest in a test such as ILIU's OA test.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Tuesday’s session are Forest Laboratories Inc.(FRX), Coca-Cola Co.(KO) and Waste Management Inc.(WM)
- [By Johanna Bennett]
Forest Laboratories (FRX) surged 9.7% to close at $56.32, marking the biggest gain in the S&P 500. The drug maker unveiled plans to trim $500 million in costs, and spend at least $400 million buying back its stock.
- [By Mani]
Investors of Forest Laboratories, Inc. (NYSE: FRX) is banking on the prospect that Forest, under its newly anointed CEO, will simply become more specialized, shedding salesforce expenses along the way.
Top Japanese Stocks To Invest In Right Now: RealPage Inc.(RP)
RealPage, Inc. provides on demand software solutions for the rental housing industry in North America. It offers property management systems, including OneSite to manage leasing and rents, facilities, purchasing, accounting, budgeting, and living of multi-family, housing and urban development (HUD), tax credit, privatized military housing, and student housing; and Propertyware for accounting, maintenance and work order management, marketing spend management, and portal services, as well as screening, renter?s insurance, and payment solutions. The company also provides on premise property management systems that include RentRoll for small conventional apartment communities; HUD Manager for small HUD, rural housing services, and tax credit subsidized apartment communities; Tenant Pro for small conventional properties; Spectra, an apartment and commercial modular property management system; and i-CAM and Management Plus property management software that automates and streaml ines rental activities. In addition, it offers software-enabled value-added services, such as LeaseStar, a system that manage marketing and leasing operations and enable owners and managers to originate, capture, track, manage, and close leads; YieldStar, a scientific yield management system, which enables owners and managers to optimize rents; LeasingDesk, a risk mitigation system to reduce delinquency, liability, and property damage risk; and Velocity that offers billing and utility management services; OpsTechnology that offers spend management systems that enable owners and managers to control costs; shared cloud services, which are integrated with property management systems and software-enabled valued added services; and RealPage Senior Living, an integrated care management, community management, and marketing management platform. The company sells its software and services directly through its sales force. RealPage, Inc. is headquartered in Carrollton, Texas.
Advisors' Opinion:- [By Sean Williams]
For this week's round of "Better Know a Stock," I'm going to take a closer look at RealPage (NASDAQ: RP ) .
What RealPage does
RealPage is a software-as-a-service applications provider to apartment communities and single-family housing developments. The company has a portfolio of cloud-based software products that allow apartment communities to automate leasing, renting, management, and accounting activities. It also provides software capable of helping apartments originate and find new leads, as well as optimize rent yields. - [By John Udovich]
Small cap construction software stock Textura Corp (NYSE: TXTR) has been all over the place lately, meaning it might be time to take a look at it along with other small cap or mid cap construction, design or real estate software stocks like RealPage, Inc (NASDAQ: RP) and more well known Autodesk, Inc (NASDAQ: ADSK). After all, enterprise software stocks like these would offer a more indirect way to bet on a housing or construction ��ecovery,���ust like building materials stocks; plus earlier this summer,�a benchmark global study (sponsored by Textura Corp) called Global Construction 2025 predicted that the global construction market will grow by more than 70% to reach $15 trillion by 2025.�
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on RealPage (Nasdaq: RP ) , whose recent revenue and earnings are plotted below. - [By Alex Planes]
What: Shares of RealPage (NASDAQ: RP ) have been rising since an early morning plunge that shaved more than 11% off their value, and now seem to have stabilized at a loss of about 4% from the previous trading day. Investors seem somewhat displeased that the company's financial results and forward guidance were all so average.
Top Japanese Stocks To Invest In Right Now: CLARCOR Inc. (CLC)
CLARCOR Inc. provides filtration products, filtration systems and services, and consumer and industrial packaging products worldwide. Its Engine/Mobile Filtration segment offers oil, air, fuel, coolant, transmission, and hydraulic fluid filters for engines used in stationary power generation and mobile equipment applications, as well as for marine, construction, industrial, mining, and agricultural equipment. This segment also provides dust collection cartridges for environmental filtration applications The company�s Industrial/Environmental Filtration segment manufactures specialty industrial process liquid filters; filters for pharmaceutical processes and beverages; filtration systems, filters, and coalescers for the oil and natural gas industry; filtration systems for aircraft refueling, anti-pollution, sewage treatment, and water recycling; bilge water separators; sand control filters for oil and gas drilling; and woven wire and metallic products for filtration of pl astics and polymer fibers. This segment also offers antimicrobial treated filters and electronic air cleaners for use in commercial and residential buildings, hospitals, factories, residences, paint spray booths, gas turbine and dust collector systems, medical facilities, motor vehicle and aircraft cabins, clean rooms, and compressors. Its Packaging segment provides metal, plastic, and a combination of metal/plastic containers and closures for packing dry and paste form products, smokeless tobacco products, lip balms, ointments, and consumer healthcare products. This segment also offers shells for dry batteries; canisters for films and candles; spools for insulated and fine wire; and custom decorated flat metal sheets. The company distributes its products through independent distributors, dealers for original equipment manufacturers, retail stores, and internal sales force, as well as directly to end-use customers. CLARCOR Inc. was founded in 1904 and is headquartered in Fra nklin, Tennessee.
Advisors' Opinion:- [By Tom Lydon]
Top holdings based on the index include Acadia Healthcare Companies (ACHC), Amsurg Corporation (AMSG), Brookdale Senior Living (BKD), Clarcor (CLC) and Community Health Systems (CYH).
- [By Diane Alter]
Dividend Stocks That Increased Payout in September
Accenture plc (NYSE: ACN) announced a 14.8%, or $0.12 per share, increase to its semiannual dividend. The management consulting firm will now pay a semiannual dividend of $0.93. Shares yield 2.53%. Agruim Inc. (NYSE: AGU) boosted its dividend by $1.00 per share to a total dividend of $3.00 on an annualized basis. Shares of the global retailer of agricultural products now sprout a 3.54% yield. Air Industries Group Inc. (NYSE: AIRI) doubled its dividend to $0.125 per share. The maker of airplane and helicopter parts now floats a lofty yield of 6.6%. Alexandria Real Estate Equities Inc. (NYSE: ARE) upped its dividend 4.6% to $0.68 per quarter for a yield of 4.21%. Banner Corp. (Nasdaq: BANR) boosted its quarterly dividend 25% to $0.15 per share. The parent company of Banner and Islander Bank serves the Pacific Northwest region. Brady Corp. (NYSE: BRC) lifted its quarterly dividend 2.6% to $0.78 per share. It was the 28th straight dividend increase from the identification solutions company. Shares yield 2.57%. Campbell Soup Co. (NSE: CPB) raised its quarterly dividend to $0.31 per share, up from $0.29. The company last raised its dividend in November 2010. Shares yield a hearty 3.06%. CLARCOR Inc. (NYSE: CLC) raised its quarterly dividend 26% to $0.17 per share. It's the largest percentage increase from the Tennessee-based diversified marketer of mobile filtration and packaging products in the last 20 years, and it continues the company's consecutive streak of increasing dividends for the last 30 years. Franklin Resources Inc. (NYSE: BEN) boosted its quarterly dividend 2.6% to $0.10 per share. Frisch's Restaurants Inc. (NYSE: FRS) increased its quarterly dividend 12.5% to $0.18. Shares yield 3.10% The Goodyear Tire & Rubber Company (NYSE: GT), in a move that suggests good times are ahead, reinstated its dividend at $0.05 per share. Good - [By Marc Bastow]
Filtration and packaging product provider Clarcor (CLC) announced a 26% dividend increase to 17 cents per share, payable Oct. 18 to shareholders of record as of Oct. 11.
CLC Dividend Yield: 1.22%
No comments:
Post a Comment